What is NDC 72493-103?

72493-103 is the product NDC for Jelmyto (mitomycin) kit, listed with the FDA by UroGen Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

UroGen Pharma, Inc., NDC labeler code 72493. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Jelmyto?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Jelmyto NDC 72493-103 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72493-103Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72493-0103Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72493-103-03	7249301030372493010303	1 KIT in 1 CARTON (72493-103-03) * 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72493-101-40) * 20 mL in 1 VIAL, SINGLE-DOSE (72493-102-20)Marketed from May 1, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Jelmyto
Generic name (nonproprietary): mitomycin
Dosage form: Kit
Labeler: UroGen Pharma, Inc.NDC labeler code 72493
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 211728
Marketing start: May 1, 2020
Listing expires: Dec 31, 2026
Identifiers: Product ID 72493-103_e545c060-c1c8-43af-b77e-7e951af59e1dSPL ID e545c060-c1c8-43af-b77e-7e951af59e1dSPL set ID 3d3d5053-5427-4a68-a40b-edb60699521eRxCUI 2375818, 2375823

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N472493010303 followed by a unit qualifier and the quantity

Package 72493-0103-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 9, 2025.

Indications (excerpt from the label)

JELMYTO ® is indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC). JELMYTO is an alkylating drug indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72493-103

What is NDC 72493-103?: 72493-103 is the product NDC for Jelmyto (mitomycin) kit, listed with the FDA by UroGen Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Jelmyto (Mitomycin).
Who is the labeler?: UroGen Pharma, Inc., NDC labeler code 72493. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Jelmyto?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Jelmyto (Mitomycin) NDC 72493-103